These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 14655831)

  • 1. Citalopram in anorexia nervosa.
    Pallanti S; Quercioli L; Ramacciotti A
    Eat Weight Disord; 1997 Dec; 2(4):216-21. PubMed ID: 14655831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of citalopram in anorexia nervosa: a pilot study.
    Fassino S; Leombruni P; Daga G; Brustolin A; Migliaretti G; Cavallo F; Rovera G
    Eur Neuropsychopharmacol; 2002 Oct; 12(5):453-9. PubMed ID: 12208563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of citalopram in an integrated approach to the treatment of eating disorders: an open study.
    Calandra C; Gulino V; Inserra L; Giuffrida A
    Eat Weight Disord; 1999 Dec; 4(4):207-10. PubMed ID: 10728184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Six-month open trial of haloperidol as an adjunctive treatment for anorexia nervosa: a preliminary report.
    Cassano GB; Miniati M; Pini S; Rotondo A; Banti S; Borri C; Camilleri V; Mauri M
    Int J Eat Disord; 2003 Mar; 33(2):172-7. PubMed ID: 12616583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    Lenox-Smith AJ; Jiang Q
    Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are serotonin selective reuptake inhibitors effective in underweight anorexia nervosa?
    Ferguson CP; La Via MC; Crossan PJ; Kaye WH
    Int J Eat Disord; 1999 Jan; 25(1):11-7. PubMed ID: 9924648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective study of SSRI treatment in adolescent anorexia nervosa: insufficient evidence for efficacy.
    Holtkamp K; Konrad K; Kaiser N; Ploenes Y; Heussen N; Grzella I; Herpertz-Dahlmann B
    J Psychiatr Res; 2005 May; 39(3):303-10. PubMed ID: 15725429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Citalopram in the treatment of binge-eating disorder: a placebo-controlled trial.
    McElroy SL; Hudson JI; Malhotra S; Welge JA; Nelson EB; Keck PE
    J Clin Psychiatry; 2003 Jul; 64(7):807-13. PubMed ID: 12934982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olanzapine in the treatment of anorexia nervosa: an open label trial.
    Powers PS; Santana CA; Bannon YS
    Int J Eat Disord; 2002 Sep; 32(2):146-54. PubMed ID: 12210656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olanzapine treatment of anorexia nervosa: a retrospective study.
    Malina A; Gaskill J; McConaha C; Frank GK; LaVia M; Scholar L; Kaye WH
    Int J Eat Disord; 2003 Mar; 33(2):234-7. PubMed ID: 12616591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relapse prevention and selective serotonin reuptake inhibitor medication in two adolescents with anorexia nervosa.
    Luzier J; Rached K; Talley J
    Int J Eat Disord; 2019 Jul; 52(7):863-867. PubMed ID: 31081553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does percent body fat predict outcome in anorexia nervosa?
    Mayer LE; Roberto CA; Glasofer DR; Etu SF; Gallagher D; Wang J; Heymsfield SB; Pierson RN; Attia E; Devlin MJ; Walsh BT
    Am J Psychiatry; 2007 Jun; 164(6):970-2. PubMed ID: 17541059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of anorexia nervosa with exercise and selective serotonergic reuptake inhibitors.
    Rosenblum J; Forman SF
    Curr Opin Pediatr; 2003 Jun; 15(3):346-7. PubMed ID: 12806270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective serotonin reuptake inhibitors in anorexia.
    Bergh C; Eriksson M; Lindberg G; Södersten P
    Lancet; 1996 Nov; 348(9039):1459-60. PubMed ID: 8937313
    [No Abstract]   [Full Text] [Related]  

  • 15. Escitalopram should be investigated in anorexia nervosa: Rationale and review of mechanisms.
    Strumila R; Lengvenyte A; Olie E; Courtet P; Guillaume S
    J Psychopharmacol; 2022 Sep; 36(9):1016-1019. PubMed ID: 36003008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective serotonin re-uptake inhibitors in anorexia nervosa.
    Vaswani M; Kalra H
    Expert Opin Investig Drugs; 2004 Apr; 13(4):349-57. PubMed ID: 15102585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Similarities and differences between excessive exercising anorexia nervosa patients compared with DSM-IV defined anorexia nervosa subtypes.
    Kiezebrink K; Campbell D; Mann E; Blundell J
    Eat Weight Disord; 2009 Dec; 14(4):e199-204. PubMed ID: 20179406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Citalopram versus fluoxetine for the treatment of patients with bulimia nervosa: a single-blind randomized controlled trial.
    Leombruni P; Amianto F; Delsedime N; Gramaglia C; Abbate-Daga G; Fassino S
    Adv Ther; 2006; 23(3):481-94. PubMed ID: 16912031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluoxetine after weight restoration in anorexia nervosa: a randomized controlled trial.
    Walsh BT; Kaplan AS; Attia E; Olmsted M; Parides M; Carter JC; Pike KM; Devlin MJ; Woodside B; Roberto CA; Rockert W
    JAMA; 2006 Jun; 295(22):2605-12. PubMed ID: 16772623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind placebo-controlled administration of fluoxetine in restricting- and restricting-purging-type anorexia nervosa.
    Kaye WH; Nagata T; Weltzin TE; Hsu LK; Sokol MS; McConaha C; Plotnicov KH; Weise J; Deep D
    Biol Psychiatry; 2001 Apr; 49(7):644-52. PubMed ID: 11297722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.